Dynatronics (NASDAQ:DYNT) has been assigned a $3.00 price objective by stock analysts at Maxim Group in a report issued on Thursday, TipRanks reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. Maxim Group’s price target would indicate a potential upside of 197.03% from the stock’s current price.
Other equities research analysts have also issued research reports about the company. Aegis began coverage on Dynatronics in a research note on Wednesday, June 5th. They set a “buy” rating on the stock. ValuEngine upgraded Dynatronics from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Finally, Zacks Investment Research upgraded Dynatronics from a “sell” rating to a “hold” rating in a research note on Tuesday, July 16th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Dynatronics currently has a consensus rating of “Buy” and a consensus target price of $3.50.
DYNT traded up $0.01 on Thursday, hitting $1.01. The company had a trading volume of 3,000 shares, compared to its average volume of 8,146. The stock has a fifty day moving average price of $1.29 and a 200-day moving average price of $1.63. Dynatronics has a 12-month low of $1.00 and a 12-month high of $2.99. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.60 and a current ratio of 1.39. The stock has a market capitalization of $8.68 million, a price-to-earnings ratio of -4.81 and a beta of 0.13.
Dynatronics (NASDAQ:DYNT) last posted its earnings results on Wednesday, September 25th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.01. Dynatronics had a negative return on equity of 9.65% and a negative net margin of 1.47%. The company had revenue of $15.51 million for the quarter, compared to analyst estimates of $14.96 million. Analysts forecast that Dynatronics will post -0.15 EPS for the current fiscal year.
An institutional investor recently raised its position in Dynatronics stock. Vanguard Group Inc. lifted its holdings in shares of Dynatronics Co. (NASDAQ:DYNT) by 76.4% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 50,484 shares of the medical equipment provider’s stock after acquiring an additional 21,870 shares during the period. Vanguard Group Inc. owned approximately 0.60% of Dynatronics worth $83,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 13.11% of the company’s stock.
Dynatronics Company Profile
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
Featured Story: Is it Safe to Invest in Commodities?
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.